Sciclone Pharma (SCLN) Reports Q3 EPS of $0.26
Tweet
Share
E-mailGet Alerts SCLN Hot Sheet
Price: $11.15 --0%
Financial Fact:
Research and development: 3.29M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Research and development: 3.29M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Sciclone Pharma (NASDAQ: SCLN) reported Q3 EPS of $0.2, versus $0.17 reported last year. Revenue for the quarter came in at $42.9 million, versus $34.3 million reported last year.
For earnings history and earnings-related data on Sciclone Pharma (SCLN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
- Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
